PharmChem Inc
PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.
PharmChem Inc (PCHM) - Total Liabilities
Latest total liabilities as of December 2024: $585.39K USD
Based on the latest financial reports, PharmChem Inc (PCHM) has total liabilities worth $585.39K USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
PharmChem Inc - Total Liabilities Trend (1989–2024)
This chart illustrates how PharmChem Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
PharmChem Inc Competitors by Total Liabilities
The table below lists competitors of PharmChem Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Schroder Real Estate Investment Trust Ltd
LSE:SREI
|
UK | GBX199.08 Million |
|
NAVIGATOR COMPANY (PO9.SG)
STU:PO9
|
Germany | €1.78 Billion |
|
SHARP CORP OSAKA - Dusseldorf Stock Exchang
DU:SRP
|
Germany | €1.43 Trillion |
|
PORTUCEL
BE:PO9
|
Germany | €1.78 Billion |
|
H.W.A. AG - Dusseldorf Stock Exchang
DU:H9W
|
Germany | €29.01 Million |
Liability Composition Analysis (1989–2024)
This chart breaks down PharmChem Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PharmChem Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PharmChem Inc (1989–2024)
The table below shows the annual total liabilities of PharmChem Inc from 1989 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $585.39K | +4.79% |
| 2023-12-31 | $558.65K | +24.91% |
| 2022-12-31 | $447.23K | -17.56% |
| 2021-12-31 | $542.46K | -52.47% |
| 2020-12-31 | $1.14 Million | +45.32% |
| 2019-12-31 | $785.27K | +5.52% |
| 2018-12-31 | $744.18K | +13.10% |
| 2017-12-31 | $658.00K | +11.75% |
| 2016-12-31 | $588.81K | -93.00% |
| 2003-12-31 | $8.41 Million | -31.68% |
| 2002-12-31 | $12.31 Million | -43.43% |
| 2001-12-31 | $21.76 Million | +77.33% |
| 2000-12-31 | $12.27 Million | +8.12% |
| 1999-12-31 | $11.35 Million | +1.76% |
| 1998-12-31 | $11.15 Million | -6.80% |
| 1997-12-31 | $11.97 Million | +17.54% |
| 1996-12-31 | $10.18 Million | -9.10% |
| 1995-12-31 | $11.20 Million | +6.67% |
| 1994-12-31 | $10.50 Million | -7.08% |
| 1993-12-31 | $11.30 Million | +14.14% |
| 1992-12-31 | $9.90 Million | +115.22% |
| 1991-12-31 | $4.60 Million | +15.00% |
| 1990-12-31 | $4.00 Million | +33.33% |
| 1989-12-31 | $3.00 Million | -- |